Ownership history in BB BIOTECH AG · 45 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Inc. Common Stock (ALXN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | UNCHANGED | 1,314,428 | — | 0% | 4.47% | $177.7M | — |
| 2018 Q4 | UNCHANGED | 1,314,428 | — | 0% | 4.10% | $128.0M | — |
| 2018 Q3 | REDUCED | 1,314,428 | -30,000 | -2.2% | 4.84% | $182.7M | — |
| 2018 Q2 | REDUCED | 1,344,428 | -50,000 | -3.6% | 4.82% | $166.9M | — |
| 2018 Q1 | ADDED | 1,394,428 | +40,000 | +3.0% | 4.30% | $155.4M | — |
| 2017 Q4 | UNCHANGED | 1,354,428 | — | 0% | 4.56% | $162.0M | — |
| 2017 Q3 | UNCHANGED | 1,354,428 | — | 0% | 5.26% | $190.0M | — |
| 2017 Q2 | ADDED | 1,354,428 | +125,000 | +10.2% | 5.04% | $164.8M | — |
| 2017 Q1 | UNCHANGED | 1,229,428 | — | 0% | 4.88% | $149.1M | — |
| 2016 Q4 | ADDED | 1,229,428 | +50,000 | +4.2% | 5.57% | $150.4M | — |